Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yesim Dargaud

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
Hamostaseologie|June 20, 2025
Hereditary Combined Deficiency of the Vitamin K-Dependent Coagulation FactorsAlexandre Raharimanana, Séverine Cunat, Céline Falaise, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 21, 2022
Development of simple and rapid method for Emicizumab quantification by LC-MS/MS in human plasmaLaurie Josset, Sophie Hodin, Sandrine Delinger, et al.
Thrombosis Research|October 2, 2012
Human hepatoma cell line HuH-7 is an effective cellular system to produce recombinant factor IX with improved post-translational modificationsNathalie Enjolras, Yesim Dargaud, Eloïse Pérot, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 13, 2021
Haemostatic effect of adding tranexamic acid to emicizumab prophylaxis in severe haemophilia A: A preclinical studyMaissa Janbain, Nathalie Enjolras, Radu Bolbos, et al.
Haematologica|February 24, 2018
Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumabYesim Dargaud, Anne Lienhart, Maissaa Janbain, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2024
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspectiveWolfgang Miesbach, Manuel Carcao, Johnny Mahlangu, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 30, 2003
Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia AYesim Dargaud, Battistina Buono Cruchaudet, Anne Lienhart, et al.
Archives of Gynecology and Obstetrics|April 28, 2024
The obstetrical consequences of ischemic stroke in women of childbearing ageJeremy David, Helene Desmurs-Clavel, Laura Mechtouff, et al.
Thrombosis and Haemostasis|November 20, 2018
Fusion of Factor IX to Factor XIII-B Sub-Unit Improves the Pharmacokinetic Profile of Factor IXSandra Le Quellec, Nathalie Enjolras, Eloïse Perot, et al.
JMIR Research Protocols|March 8, 2023
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick ModelLaurie Fraticelli, Julie Freyssenge, Emilie Promé-Combel, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Hamostaseologie|June 20, 2025
Hereditary Combined Deficiency of the Vitamin K-Dependent Coagulation FactorsAlexandre Raharimanana, Séverine Cunat, Céline Falaise, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 21, 2022
Development of simple and rapid method for Emicizumab quantification by LC-MS/MS in human plasmaLaurie Josset, Sophie Hodin, Sandrine Delinger, et al.
Thrombosis Research|October 2, 2012
Human hepatoma cell line HuH-7 is an effective cellular system to produce recombinant factor IX with improved post-translational modificationsNathalie Enjolras, Yesim Dargaud, Eloïse Pérot, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 13, 2021
Haemostatic effect of adding tranexamic acid to emicizumab prophylaxis in severe haemophilia A: A preclinical studyMaissa Janbain, Nathalie Enjolras, Radu Bolbos, et al.
Haematologica|February 24, 2018
Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumabYesim Dargaud, Anne Lienhart, Maissaa Janbain, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2024
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspectiveWolfgang Miesbach, Manuel Carcao, Johnny Mahlangu, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 30, 2003
Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia AYesim Dargaud, Battistina Buono Cruchaudet, Anne Lienhart, et al.
Archives of Gynecology and Obstetrics|April 28, 2024
The obstetrical consequences of ischemic stroke in women of childbearing ageJeremy David, Helene Desmurs-Clavel, Laura Mechtouff, et al.
Thrombosis and Haemostasis|November 20, 2018
Fusion of Factor IX to Factor XIII-B Sub-Unit Improves the Pharmacokinetic Profile of Factor IXSandra Le Quellec, Nathalie Enjolras, Eloïse Perot, et al.
JMIR Research Protocols|March 8, 2023
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick ModelLaurie Fraticelli, Julie Freyssenge, Emilie Promé-Combel, et al.
Pageof 13